Olivier Meilhac Selected Research

LDL Lipoproteins (beta Lipoproteins)

12/2021	Antioxidant and Cytoprotective Properties of Polyphenol-Rich Extracts from Antirhea borbonica and Doratoxylon apetalum against Atherogenic Lipids in Human Endothelial Cells.
9/2012	Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Meilhac Research Topics

Disease

25	Thrombosis (Thrombus) 04/2016 - 06/2003
22	Atherosclerosis 04/2024 - 11/2002
18	Atherosclerotic Plaque (Atheroma) 12/2021 - 06/2003
15	Inflammation (Inflammations) 04/2024 - 03/2011
14	Stroke (Strokes) 04/2024 - 07/2010
14	Abdominal Aortic Aneurysm 12/2016 - 06/2004
11	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2006
11	Sepsis (Septicemia) 01/2023 - 12/2017
11	Hyperglycemia 04/2022 - 01/2017
9	COVID-19 02/2023 - 01/2020
9	Infarction (Infarctions) 05/2022 - 11/2005
9	Ischemic Stroke 05/2022 - 04/2013
9	Aneurysm (Aneurysms) 02/2016 - 06/2004
8	Obesity 04/2024 - 01/2013
8	Rupture 09/2021 - 03/2007
7	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2012
6	Hemorrhage 06/2016 - 12/2007
5	Insulin Resistance 01/2023 - 01/2017
5	Periodontitis 01/2022 - 09/2012
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2012
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022 - 10/2019
4	Hemolysis 10/2020 - 09/2012
4	Myocardial Infarction 01/2018 - 10/2004
4	Ischemia 01/2018 - 04/2011
4	Acute Coronary Syndrome 11/2014 - 07/2005
4	Cicatrix (Scar) 12/2011 - 05/2002
3	Brain Infarction 04/2022 - 04/2011
3	Coronary Disease (Coronary Heart Disease) 12/2021 - 04/2014
3	Fibrosis (Cirrhosis) 03/2021 - 12/2011
2	Fatty Liver 04/2024 - 01/2020
2	Dyslipidemias (Dyslipidemia) 04/2022 - 07/2005
2	Brain Ischemia (Cerebral Ischemia) 10/2021 - 10/2014
2	Diabetes Mellitus 01/2021 - 01/2018
2	Vascular Calcification 10/2020 - 11/2018
2	Pneumonia (Pneumonitis) 01/2020 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 10/2004
2	Cerebral Infarction 01/2020 - 10/2016
2	Reperfusion Injury 01/2018 - 12/2011

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2005
16	HDL LipoproteinsIBA 04/2024 - 07/2010
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
14	LipidsIBA 04/2024 - 10/2006
12	Lipoproteins (Lipoprotein)IBA 01/2022 - 11/2002
11	Phenobarbital (Luminal)FDA Link 02/2016 - 06/2004
11	Peptide Hydrolases (Proteases)FDA Link 05/2013 - 05/2002
9	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2013
9	HDL CholesterolIBA 01/2023 - 06/2015
9	Pancreatic Elastase (Elastase)IBA 02/2016 - 05/2002
8	AntioxidantsIBA 04/2022 - 11/2013
6	CholesterolIBA 04/2024 - 08/2012
6	Insulin (Novolin)FDA Link 12/2023 - 01/2019
6	PolyphenolsIBA 04/2022 - 01/2017
6	Hemoglobins (Hemoglobin)IBA 10/2021 - 12/2007
6	CytokinesIBA 09/2021 - 01/2012
6	Advanced Glycation End ProductsIBA 01/2021 - 01/2017
6	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 05/2002
5	Interleukin-6 (Interleukin 6)IBA 04/2023 - 07/2005
5	oxidized low density lipoproteinIBA 02/2023 - 10/2014
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 09/2012
5	Conditioned Culture MediaIBA 08/2013 - 12/2007
4	AdiponectinIBA 04/2023 - 10/2019
4	Neuroprotective AgentsIBA 05/2022 - 07/2010
4	Peptides (Polypeptides)IBA 01/2022 - 02/2010
3	EnzymesIBA 04/2023 - 06/2006
3	Apolipoproteins E (ApoE)IBA 02/2023 - 11/2018
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2023 - 06/2015
3	C-Reactive ProteinIBA 01/2023 - 07/2005
3	caffeic acidIBA 04/2022 - 01/2020
3	Lipoprotein(a)IBA 01/2022 - 01/2018
3	LDL CholesterolIBA 01/2021 - 10/2014
3	ProteomeIBA 01/2021 - 09/2012
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020 - 05/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2019 - 04/2007
3	SubtilisinIBA 01/2018 - 08/2012
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 05/2014
3	Fibrinolysin FDA Link 02/2012 - 05/2002
3	HSP27 Heat-Shock ProteinsIBA 01/2008 - 10/2004
2	ApolipoproteinsIBA 04/2024 - 02/2023
2	LeptinIBA 04/2023 - 01/2023
2	EpitopesIBA 04/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 04/2022 - 01/2022
2	VaccinesIBA 04/2022 - 01/2022
2	BNT162 VaccineIBA 04/2022 - 01/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2021 - 09/2012
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021 - 02/2012
2	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 10/2021 - 11/2014
2	Peroxidase (Myeloperoxidase)IBA 10/2021 - 12/2007
2	Sirolimus (Rapamycin)FDA Link 12/2020 - 01/2020
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2020 - 07/2010
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2019
2	LigandsIBA 05/2019 - 04/2014
2	CatalaseIBA 01/2019 - 12/2011
2	ischemia-modified albuminIBA 01/2018 - 01/2017

Therapy/Procedure

16	Therapeutics 04/2024 - 10/2006
3	Intraperitoneal Injections 10/2021 - 01/2017
3	Ligation 01/2020 - 11/2005
3	Lasers (Laser) 04/2011 - 07/2008
2	Intravenous Injections 01/2020 - 03/2013
2	Carotid Endarterectomy 11/2018 - 01/2012